Glaxo’s Dirty Tricks At The Dolin Trial..

Good analysis of the current state of play at the Dolin Paxil suicide trial which began yesterday. GSK, of course, deny that Paxil played a part in Stewart Dolin’s suicide. Remarkable really, considering that Paxil/Seroxat is possibly the most controversial drug ,in relation to suicide, of recent times. GSK have been getting away with blaming the victim in various instances because Paxil/Seroxat is almost always prescribed to vulnerable people, so it’s easy for them to blame the individual and not the effects of the drug. Seroxat/Paxil definitely made me extremely suicidal, and I know it did to many others too.

From Fiddaman:

Wednesday, March 15, 2017

Dolin v GSK – Opening Arguments

Day one of Dolin v GSK is over and, as expected, GSK are, it appears, trying to muddy the name of the victim, Stewart Dolin.

David E. Rapoport opened the arguments on behalf of Stewart Dolin’s widow, Wendy. He explained to them how, in 1989, GSK submitted  its “Integrated Summary of Safety Information” to seek approval of Paxil for adult depression. He also explained to the jury how the submission conveniently hid the link to Paxil being responsible for inducing suicide and suicidal thinking in patients during the clinical trials. (Back story) Rapoport also told the jury about Stewart’s life and how he had, in the past, been prescribed Paxil and Sertraline (Zoloft).

GSK made several objections, one of which was the objection to Rapoport’s use of the word “Paxil” – Part of GSK’s defence is that Stewart took a generic version of Paxil made by Mylan, ergo they are not responsible for his Paxil induced suicide – I say “Paxil” because whoever manufactured it after the patent ran out did so using GSK’s brand, a brand that became a household name. Stewart’s prescribing doctor even referred to it as Paxil. It was a churlish objection from GSK and one that, I think, will have little or no bearing on the outcome of this trial.

All in all, Rapoport spoke for around two hours, after which the Judge called for a 15 minute recess.

Next up was GSK, represented, in part by Andrew Bayman of King & Spalding, and, as expected, they were slick and focused on Stewart Dolin’s mental state at the time of his death. They tried to state that Stewart Dolin had work related problems which caused his “suicide”. Interestingly, they also claimed that Paxil does not cause suicide. So, effectively, every single person that has died by suicide whilst on Paxil did not die by suicide because of Paxil. Hard to believe given the amount of men, women and children that have died by violent suicide whilst taking Paxil.

GSK was represented by Andrew Bayman of King & Spalding and not Dentons as previously stated.

The fact that Paxil has a black-box warning was brushed over by GSK who claimed that the black box warning was put in place for all SSRIs and was meant as a red flag for prescribing physicians to monitor their patients.

GSK’s lawyer told the jury that he intended to speak for just an hour, an attempt at point-scoring exercise if ever I’ve seen one. However, approaching the hour the Judge intervened and told him his hour was almost up. He responded by saying he just needed to summarize which he plans to do do tomorrow morning.

Opening arguments is basically two parties setting out their stall. It was pretty obvious that GSK would go down this route (blame the victim). During the lead-up to this trial they have targeted Stewart’s widow, children, friends and expert witnesses.

Tomorrow morning they will no doubt reiterate their “blame-the-victim mantra” they tried to sell today. It’s the only defence they seem to have.

Bob Fiddaman.

Dolin Back Stories



  1. Nick

    This is also the prescribers fault too, as i’ve mentioned before if you react badly within a few days, that is your body rejecting it and alternative should be explored. The prescribers role should be to closely monitor the patients behaviour.

    Day 2 of taking Seroxat, I was fine, minus the weight gain, Paroxetine suited me, whereas Citalopram and Sertraline did not and rather than stopping after a few days, I continued using it and nobody monitored my behaviour. Now we would hear many success stories about Citalopram and Sertraline.

    The longer you are on a drug, the longer and harder it is to get off with Paroxetine and Venlafaxine being the toughest which is why you should quit as soon as possible if a particular one doesn’t suit you.

    Now you mention in the story about GSK not being responsible for generics. This is exactly what I mentioned to you months ago about generics, they make it harder to take manufacturers and licence holders to court. Until last year there were NO generic manufacturers of Paroxetine in the UK possibly because of bad media coverage of Seroxat.

    As for severe withdrawal symptoms, I ran out of Venlafaxine and trust me missing one or two doses is a very bad experience, I found some old but still in date Zyprexa(Olanzapine) and took 20mg of it and eased down the withdrawal effect vastly. So i’m wondering if use of this antipsychotic intermittently as and when needed when withdrawal symptoms are severe maybe good for getting off SSRIs and SNRIs.

    I also mentioned Piriton (Behind the counter) also helped ease of withdrawal symptoms. This is something that needs to be looked at to develop a safe and comfortable taper off programme.

  2. Nick

    About a year and stopped last July, I immediately switched to Venlafaxine, I did feel weird for a week or so and then I got used to the new drug.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s